1
|
Vera OD, Wulff H, Braun AP. Endothelial KCa channels: Novel targets to reduce atherosclerosis-driven vascular dysfunction. Front Pharmacol 2023; 14:1151244. [PMID: 37063294 PMCID: PMC10102451 DOI: 10.3389/fphar.2023.1151244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2023] [Accepted: 03/24/2023] [Indexed: 04/03/2023] Open
Abstract
Elevated levels of cholesterol in the blood can induce endothelial dysfunction, a condition characterized by impaired nitric oxide production and decreased vasodilatory capacity. Endothelial dysfunction can promote vascular disease, such as atherosclerosis, where macrophages accumulate in the vascular intima and fatty plaques form that impair normal blood flow in conduit arteries. Current pharmacological strategies to treat atherosclerosis mostly focus on lipid lowering to prevent high levels of plasma cholesterol that induce endothelial dysfunction and atherosclerosis. While this approach is effective for most patients with atherosclerosis, for some, lipid lowering is not enough to reduce their cardiovascular risk factors associated with atherosclerosis (e.g., hypertension, cardiac dysfunction, stroke, etc.). For such patients, additional strategies targeted at reducing endothelial dysfunction may be beneficial. One novel strategy to restore endothelial function and mitigate atherosclerosis risk is to enhance the activity of Ca2+-activated K+ (KCa) channels in the endothelium with positive gating modulator drugs. Here, we review the mechanism of action of these small molecules and discuss their ability to improve endothelial function. We then explore how this strategy could mitigate endothelial dysfunction in the context of atherosclerosis by examining how KCa modulators can improve cardiovascular function in other settings, such as aging and type 2 diabetes. Finally, we consider questions that will need to be addressed to determine whether KCa channel activation could be used as a long-term add-on to lipid lowering to augment atherosclerosis treatment, particularly in patients where lipid-lowering is not adequate to improve their cardiovascular health.
Collapse
Affiliation(s)
- O. Daniel Vera
- Department of Physiology and Pharmacology, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
| | - Heike Wulff
- Department of Pharmacology, School of Medicine, University of California, Davis, CA, United States
| | - Andrew P. Braun
- Department of Physiology and Pharmacology, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
- *Correspondence: Andrew P. Braun,
| |
Collapse
|
2
|
Wulff H, Braun AP, Alper SL. Can KCa3.1 channel activators serve as novel inhibitors of platelet aggregation? J Thromb Haemost 2022; 20:2488-2490. [PMID: 36271464 DOI: 10.1111/jth.15863] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2022] [Accepted: 08/22/2022] [Indexed: 11/26/2022]
Affiliation(s)
- Heike Wulff
- Department of Pharmacology, School of Medicine, University of California, Davis, California, USA
| | - Andrew P Braun
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Seth L Alper
- Division of Nephrology and Vascular Biology Research Center, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
| |
Collapse
|
3
|
Yang Y, Nourian Z, Li M, Sun Z, Zhang L, Davis MJ, Meininger GA, Wu J, Braun AP, Hill MA. Modification of Fibronectin by Non-Enzymatic Glycation Impairs K+ Channel Function in Rat Cerebral Artery Smooth Muscle Cells. Front Physiol 2022; 13:871968. [PMID: 35832482 PMCID: PMC9272009 DOI: 10.3389/fphys.2022.871968] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2022] [Accepted: 05/30/2022] [Indexed: 11/13/2022] Open
Abstract
Fibronectin (FN) enhances K+ channel activity by integrin-mediated mechanisms. As vascular smooth muscle (VSM) K+ channels mediate vasodilation, we hypothesized that modification of fibronectin, via advanced non-enzymatic glycation, would alter signaling of this extracellular matrix protein through these channels. Bovine FN (1 mg/ml) was glycated (gFN) for 5 days using methylglyoxal (50 mM), and albumin was similarly glycated as a non-matrix protein control. VSM cells were isolated from rat cerebral arteries for measurement of macroscopic K+ channel activity using whole cell patch clamp methodology. Pharmacological inhibitors, iberiotoxin (0.1 μM) and 4-aminopyridine (0.1 mM), were used to identify contributions of large-conductance, Ca2+-activated, K+ channels and voltage-gated K+ channels, respectively. Compared with baseline, native FN enhanced whole cell K+ current in a concentration-dependent manner, whereas gFN inhibited basal current. Furthermore, native albumin did not enhance basal K+ current, but the glycated form (gAlb) caused inhibition. gFN was shown to impair both the Kv and BKCa components of total macroscopic K+ current. Anti-integrin α5 and β1 antibodies attenuated the effects of both FN and gFN on macroscopic K+ current at +70 mV. Consistent with an action on BKCa activity, FN increased, whereas gFN decreased the frequency of spontaneous transient outward current (STOCs). In contrast, gAlb inhibited whole cell K+ current predominantly through Kv, showing little effect on STOCs. A function-blocking, anti-RAGE antibody partially reversed the inhibitory effects of gFN, suggesting involvement of this receptor. Further, gFN caused production of reactive oxygen species (ROS) by isolated VSMCs as revealed by the fluorescent indicator, DHE. Evoked ROS production was attenuated by the RAGE blocking antibody. Collectively, these studies identify ion channel-related mechanisms (integrin and ROS-mediated) by which protein glycation may modify VSMC function.
Collapse
Affiliation(s)
- Yan Yang
- Dalton Cardiovascular Research Center, Columbia, MO, United States
| | - Zahra Nourian
- Dalton Cardiovascular Research Center, Columbia, MO, United States
| | - Min Li
- Dalton Cardiovascular Research Center, Columbia, MO, United States
| | - Zhe Sun
- Dalton Cardiovascular Research Center, Columbia, MO, United States
| | | | - Michael J. Davis
- Dalton Cardiovascular Research Center, Columbia, MO, United States
- Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO, United States
| | - Gerald A. Meininger
- Dalton Cardiovascular Research Center, Columbia, MO, United States
- Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO, United States
| | - Jianbo Wu
- Southwest Medical University, Luzhou, China
| | - Andrew P. Braun
- Department of Physiology and Pharmacology, University of Calgary, Calgary, AB, Canada
| | - Michael A. Hill
- Dalton Cardiovascular Research Center, Columbia, MO, United States
- Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO, United States
- *Correspondence: Michael A. Hill,
| |
Collapse
|
4
|
Vera OD, Mishra RC, Belke DD, Hamm L, Wulff H, Braun AP. Enhancement of Endothelial KCa Channel Activity as a Novel Strategy to Oppose Atherosclerosis. FASEB J 2022. [DOI: 10.1096/fasebj.2022.36.s1.r2908] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- O. D. Vera
- Physiology and PharmacologyUniversity of CalgaryCalgaryAB
| | | | | | - Liam Hamm
- Physiology and PharmacologyUniversity of CalgaryCalgaryAB
| | | | | |
Collapse
|
5
|
Kendrick DJ, Mishra RC, John CM, Zhu HL, Braun AP. Effects of Pharmacological Inhibitors of NADPH Oxidase on Myogenic Contractility and Evoked Vasoactive Responses in Rat Resistance Arteries. Front Physiol 2022; 12:752366. [PMID: 35140625 PMCID: PMC8818784 DOI: 10.3389/fphys.2021.752366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2021] [Accepted: 12/17/2021] [Indexed: 11/17/2022] Open
Abstract
Reactive oxygen species (ROS), such as superoxide anions and hydrogen peroxide, are reported to contribute to the dynamic regulation of contractility in various arterial preparations, however, the situation in pressurized, myogenically active resistance arteries is much less clear. In the present study, we have utilized established pharmacological inhibitors of NADPH oxidase activity to examine the potential contribution of ROS to intrinsic myogenic contractility in adult Sprague–Dawley rat resistance arteries and responses to vasoactive agents acting via the endothelium (i.e., acetylcholine, SKA-31) or smooth muscle (i.e., sodium nitroprusside, phenylephrine). In cannulated and pressurized cremaster skeletal muscle and middle cerebral arteries, the NOX inhibitors 2-acetylphenothiazine (2-APT) and VAS2870, selective for NOX1 and NOX2, respectively, evoked concentration-dependent inhibition of basal myogenic tone in a reversible and irreversible manner, respectively, whereas the non-selective inhibitor apocynin augmented myogenic contractility. The vasodilatory actions of 2-APT and VAS2870 occurred primarily via the vascular endothelium and smooth muscle, respectively. Functional responses to established endothelium-dependent and –independent vasoactive agents were largely unaltered in the presence of either 2-APT or apocynin. In cremaster arteries from Type 2 Diabetic (T2D) Goto-Kakizaki rats with endothelial dysfunction, treatment with either 2-APT or apocynin did not modify stimulus-evoked vasoactive responses, but did affect basal myogenic tone. These same NOX inhibitors produced robust inhibition of total NADPH oxidase activity in aortic tissue homogenates from control and T2D rats, and NOX isozymes 1, 2 and 4, along with superoxide dismutase 1, were detected by qPCR in cremaster arteries and aorta from both species. Based on the diverse effects that we observed for established, chemically distinct NOX inhibitors, the functional contribution of vascular NADPH oxidase activity to stimulus-evoked vasoactive signaling in myogenically active, small resistance arteries remains unclear.
Collapse
|
6
|
Mishra RC, Kyle BD, Kendrick DJ, Svystonyuk D, Kieser TM, Fedak PWM, Wulff H, Braun AP. KCa channel activation normalizes endothelial function in Type 2 Diabetic resistance arteries by improving intracellular Ca 2+ mobilization. Metabolism 2021; 114:154390. [PMID: 33039407 PMCID: PMC7736096 DOI: 10.1016/j.metabol.2020.154390] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/14/2020] [Revised: 09/28/2020] [Accepted: 09/30/2020] [Indexed: 10/23/2022]
Abstract
BACKGROUND Endothelial dysfunction is an early pathogenic event in the progression of cardiovascular disease in patients with Type 2 Diabetes (T2D). Endothelial KCa2.3 and KCa3.1 K+ channels are important regulators of arterial diameter, and we thus hypothesized that SKA-31, a small molecule activator of KCa2.3 and KCa3.1, would positively influence agonist-evoked dilation in myogenically active resistance arteries in T2D. METHODOLOGY Arterial pressure myography was utilized to investigate endothelium-dependent vasodilation in isolated cremaster skeletal muscle resistance arteries from 22 to 24 week old T2D Goto-Kakizaki rats, age-matched Wistar controls, and small human intra-thoracic resistance arteries from T2D subjects. Agonist stimulated changes in cytosolic free Ca2+ in acutely isolated, single endothelial cells from Wistar and T2D Goto-Kakizaki cremaster and cerebral arteries were examined using Fura-2 fluorescence imaging. MAIN FINDINGS Endothelium-dependent vasodilation in response to acetylcholine (ACh) or bradykinin (BK) was significantly impaired in isolated cremaster arteries from T2D Goto-Kakizaki rats compared with Wistar controls, and similar results were observed in human intra-thoracic arteries. In contrast, inhibition of myogenic tone by sodium nitroprusside, a direct smooth muscle relaxant, was unaltered in both rat and human T2D arteries. Treatment with a threshold concentration of SKA-31 (0.3 μM) significantly enhanced vasodilatory responses to ACh and BK in arteries from T2D Goto-Kakizaki rats and human subjects, whereas only modest effects were observed in non-diabetic arteries of both species. Mechanistically, SKA-31 enhancement of evoked dilation was independent of vascular NO synthase and COX activities. Remarkably, SKA-31 treatment improved agonist-stimulated Ca2+ elevation in acutely isolated endothelial cells from T2D Goto-Kakizaki cremaster and cerebral arteries, but not from Wistar control vessels. In contrast, SKA-31 treatment did not affect intracellular Ca2+ release by the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor cyclopiazonic acid. CONCLUSIONS Collectively, our data demonstrate that KCa channel modulation can acutely restore endothelium-dependent vasodilatory responses in T2D resistance arteries from rats and humans, which appears to involve improved endothelial Ca2+ mobilization.
Collapse
Affiliation(s)
- Ramesh C Mishra
- Dept. of Physiology and Pharmacology, Libin Cardiovascular Institute of Alberta, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada
| | - Barry D Kyle
- Dept. of Physiology and Pharmacology, Libin Cardiovascular Institute of Alberta, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada
| | - Dylan J Kendrick
- Dept. of Physiology and Pharmacology, Libin Cardiovascular Institute of Alberta, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada
| | - Daniyil Svystonyuk
- Dept. of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada
| | - Teresa M Kieser
- Dept. of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada
| | - Paul W M Fedak
- Dept. of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada
| | - Heike Wulff
- Dept of Pharmacology, University of California Davis, 451 Health Sciences Drive, Davis, CA 95616, USA
| | - Andrew P Braun
- Dept. of Physiology and Pharmacology, Libin Cardiovascular Institute of Alberta, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.
| |
Collapse
|
7
|
Kim TY, Belke DD, Mishra RC, Braun AP. Effects of In Vivo Administration of an Endothelial KCa Channel Activator on Recovery of Cardiac Function Following Acute Myocardial Infarction in Mice. FASEB J 2020. [DOI: 10.1096/fasebj.2020.34.s1.04575] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
8
|
Mishra RC, Zhu HL, Chen SW, Cole WC, Braun AP. Loss‐ And Gain of Function Mutations in the Type 1 IP3 Receptor (IP3R1) Modify Agonist‐Evoked Vasoactive Responses in Cerebral and Skeletal Muscle Resistance Arteries From Adult Mice. FASEB J 2020. [DOI: 10.1096/fasebj.2020.34.s1.04515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
9
|
John CM, Khaddaj Mallat R, Mishra RC, George G, Singh V, Turnbull JD, Umeshappa CS, Kendrick DJ, Kim T, Fauzi FM, Visser F, Fedak PWM, Wulff H, Braun AP. SKA-31, an activator of Ca 2+-activated K + channels, improves cardiovascular function in aging. Pharmacol Res 2019; 151:104539. [PMID: 31707036 DOI: 10.1016/j.phrs.2019.104539] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/25/2019] [Revised: 10/22/2019] [Accepted: 11/06/2019] [Indexed: 12/16/2022]
Abstract
Aging represents an independent risk factor for the development of cardiovascular disease, and is associated with complex structural and functional alterations in the vasculature, such as endothelial dysfunction. Small- and intermediate-conductance, Ca2+-activated K+ channels (KCa2.3 and KCa3.1, respectively) are prominently expressed in the vascular endothelium, and pharmacological activators of these channels induce robust vasodilation upon acute exposure in isolated arteries and intact animals. However, the effects of prolonged in vivo administration of such compounds are unknown. In our study, we hypothesized that such treatment would ameliorate aging-related cardiovascular deficits. Aged (∼18 months) male Sprague Dawley rats were treated daily with either vehicle or the KCa channel activator SKA-31 (10 mg/kg, intraperitoneal injection; n = 6/group) for 8 weeks, followed by echocardiography, arterial pressure myography, immune cell and plasma cytokine characterization, and tissue histology. Our results show that SKA-31 administration improved endothelium-dependent vasodilation, reduced agonist-induced vascular contractility, and prevented the aging-associated declines in cardiac ejection fraction, stroke volume and fractional shortening, and further improved the expression of endothelial KCa channels and associated cell signalling components to levels similar to those observed in young male rats (∼5 months at end of study). SKA-31 administration did not promote pro-inflammatory changes in either T cell populations or plasma cytokines/chemokines, and we observed no overt tissue histopathology in heart, kidney, aorta, brain, liver and spleen. SKA-31 treatment in young rats had little to no effect on vascular reactivity, select protein expression, tissue histology, plasma cytokines/chemokines or immune cell properties. Collectively, these data demonstrate that administration of the KCa channel activator SKA-31 improved aging-related cardiovascular function, without adversely affecting the immune system or promoting tissue toxicity.
Collapse
Affiliation(s)
- Cini Mathew John
- Dept. of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Canada; Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Canada
| | - Rayan Khaddaj Mallat
- Dept. of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Canada; Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Canada
| | - Ramesh C Mishra
- Dept. of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Canada; Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Canada
| | - Grace George
- Dept. of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Canada; Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Canada
| | - Vikrant Singh
- Dept. of Pharmacology, University of California, Davis, USA
| | - Jeannine D Turnbull
- Dept. of Cardiac Sciences, Cumming School of Medicine, University of Calgary, Canada; Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Canada
| | - Channakeshava S Umeshappa
- Dept. of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Canada
| | - Dylan J Kendrick
- Dept. of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Canada; Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Canada
| | - Taeyeob Kim
- Dept. of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Canada; Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Canada
| | - Fazlin M Fauzi
- Dept. of Pharmacology and Chemistry, Universiti Teknologi MARA, Malaysia
| | - Frank Visser
- Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Canada
| | - Paul W M Fedak
- Dept. of Cardiac Sciences, Cumming School of Medicine, University of Calgary, Canada; Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Canada
| | - Heike Wulff
- Dept. of Pharmacology, University of California, Davis, USA
| | - Andrew P Braun
- Dept. of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Canada; Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Canada.
| |
Collapse
|
10
|
Abstract
Pancreatic islets adapt to the increase in insulin demand during pregnancy by upregulating β-cell number, insulin synthesis, and secretion. These changes require prolactin receptor (PrlR) signaling, as mice with PrlR deletion are glucose intolerant with a lower β-cell mass. Prolactin also prevents β-cell apoptosis. Many genes participate in these adaptive changes in the islet, and Lrrc55 is one of the most upregulated genes with unknown function in islets. Because Lrrc55 expression increases in parallel to the increase in β-cell number and insulin production during pregnancy, we hypothesize that Lrrc55 might regulate β-cell proliferation/apoptosis (thus β-cell number) and insulin synthesis. Here, we found that Lrrc55 expression was upregulated by >60-fold during pregnancy in a PrlR-dependent manner, and this increase was restricted only to the islets. Overexpression of Lrrc55 in β-cells had minimal effect on β-cell proliferation and glucose-stimulated insulin secretion but protected β-cells from glucolipotoxicity-induced reduction in insulin gene expression. Moreover, Lrrc55 protects β-cells from glucolipotoxicity-induced apoptosis, with upregulation of prosurvival signals and downregulation of proapoptotic signals of the endoplasmic reticulum (ER) stress pathway. Furthermore, Lrrc55 attenuated calcium depletion induced by glucolipotoxicity, which may contribute to its antiapoptotic effect. Hence our findings suggest that Lrrc55 is a novel prosurvival factor that is upregulated specifically in islets during pregnancy, and it prevents conversion of adaptive unfolded protein response to unresolved ER stress and apoptosis in β-cells. Lrrc55 could be a potential therapeutic target in diabetes by reducing ER stress and promoting β-cell survival.
Collapse
Affiliation(s)
- Guneet Makkar
- Cumming School of Medicine, Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada
| | - Vipul Shrivastava
- Cumming School of Medicine, Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada
| | - Brittyne Hlavay
- Cumming School of Medicine, Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada
| | - Marle Pretorius
- Cumming School of Medicine, Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada
| | - Barry D Kyle
- Cumming School of Medicine, Department of Physiology and Pharmacology, University of Calgary, Calgary, Canada
| | - Andrew P Braun
- Cumming School of Medicine, Department of Physiology and Pharmacology, University of Calgary, Calgary, Canada
| | - Francis C Lynn
- BC Children's Hospital Research Institute, Department of Surgery & School of Biomedical Engineering, University of British Columbia, Vancouver, Canada
| | - Carol Huang
- Cumming School of Medicine, Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Canada
| |
Collapse
|
11
|
Khaddaj Mallat R, Mathew John C, Mishra RC, Kendrick DJ, Braun AP. Pharmacological Targeting of KCa Channels to Improve Endothelial Function in the Spontaneously Hypertensive Rat. Int J Mol Sci 2019; 20:ijms20143481. [PMID: 31315169 PMCID: PMC6678254 DOI: 10.3390/ijms20143481] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2019] [Revised: 07/05/2019] [Accepted: 07/12/2019] [Indexed: 01/01/2023] Open
Abstract
Systemic hypertension is a major risk factor for the development of cardiovascular disease and is often associated with endothelial dysfunction. KCa2.3 and KCa3.1 channels are expressed in the vascular endothelium and contribute to stimulus-evoked vasodilation. We hypothesized that acute treatment with SKA-31, a selective activator of KCa2.x and KCa3.1 channels, would improve endothelium-dependent vasodilation and transiently lower mean arterial pressure (MAP) in male, spontaneously hypertensive rats (SHRs). Isolated vascular preparations exhibited impaired vasodilation in response to bradykinin (i.e., endothelial dysfunction) compared with Wistar controls, which was associated with decreased bradykinin receptor expression in mesenteric arteries. In contrast, similar levels of endothelial KCa channel expression were observed, and SKA-31 evoked vasodilation was comparable in vascular preparations from both strains. Addition of a low concentration of SKA-31 (i.e., 0.2–0.3 μM) failed to augment bradykinin-induced vasodilation in arteries from SHRs. However, responses to acetylcholine were enhanced. Surprisingly, acute bolus administration of SKA-31 in vivo (30 mg/kg, i.p. injection) modestly elevated MAP compared with vehicle injection. In summary, pharmacological targeting of endothelial KCa channels in SHRs did not readily reverse endothelial dysfunction in situ, or lower MAP in vivo. SHRs thus appear to be less responsive to endothelial KCa channel activators, which may be related to their vascular pathology.
Collapse
Affiliation(s)
- Rayan Khaddaj Mallat
- Department of Physiology and Pharmacology and Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada
| | - Cini Mathew John
- Department of Physiology and Pharmacology and Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada
| | - Ramesh C Mishra
- Department of Physiology and Pharmacology and Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada
| | - Dylan J Kendrick
- Department of Physiology and Pharmacology and Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada
| | - Andrew P Braun
- Department of Physiology and Pharmacology and Libin Cardiovascular Institute of Alberta, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.
| |
Collapse
|
12
|
Mishra RC, Rahman MM, Davis MJ, Wulff H, Hill MA, Braun AP. Alpha 1 -adrenergic stimulation selectively enhances endothelium-mediated vasodilation in rat cremaster arteries. Physiol Rep 2019; 6:e13703. [PMID: 29756401 PMCID: PMC5949301 DOI: 10.14814/phy2.13703] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2018] [Revised: 03/19/2018] [Accepted: 04/16/2018] [Indexed: 11/24/2022] Open
Abstract
We have systematically investigated how vascular smooth muscle α1‐adrenoceptor activation impacts endothelium‐mediated vasodilation in isolated, myogenically active, rat cremaster muscle 1A arteries. Cannulated cremaster arteries were pressurized intraluminally to 70 mmHg to induce myogenic tone, and exposed to vasoactive agents via bath superfusion at 34°C. Smooth muscle membrane potential was measured via sharp microelectrode recordings in pressurized, myogenic arteries. The α1‐adrenergic agonist phenylephrine (25–100 nmol/L) produced further constriction of myogenic arteries, but did not alter the vasorelaxant responses to acetylcholine (0.3 μmol/L), SKA‐31 (an activator of endothelial Ca2+‐dependent K+ channels) (3 μmol/L) or sodium nitroprusside (10 μmol/L). Exposure to 0.25–1 μmol/L phenylephrine or 1 μmol/L norepinephrine generated more robust constrictions, and also enhanced the vasodilations evoked by acetylcholine and SKA‐31, but not by sodium nitroprusside. In contrast, the thromboxane receptor agonist U46619 (250 nmol/L) dampened responses to all three vasodilators. Phenylephrine exposure depolarized myogenic arteries, and mimicking this effect with 4‐aminopyridine (1 mmol/L) was sufficient to augment the SKA‐31‐evoked vasodilation. Inhibition of L‐type Ca2+ channels by 1 μmol/L nifedipine decreased myogenic tone, phenylephrine‐induced constriction and prevented α1‐adrenergic enhancement of endothelium‐evoked vasodilation; these latter deficits were overcome by exposure to 3 and 10 μmol/L phenylephrine. Mechanistically, augmentation of ACh‐evoked dilation by phenylephrine was dampened by eNOS inhibition and abolished by blockade of endothelial KCa channels. Collectively, these data suggest that increasing α1‐adrenoceptor activation beyond a threshold level augments endothelium‐evoked vasodilation, likely by triggering transcellular signaling between smooth muscle and the endothelium. Physiologically, this negative feedback process may serve as a “brake” to limit the extent of vasoconstriction in the skeletal microcirculation evoked by the elevated sympathetic tone.
Collapse
Affiliation(s)
- Ramesh C Mishra
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Mohammad M Rahman
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Michael J Davis
- Dalton Cardiovascular Research Institute and Dept. of Medical Pharmacology and Physiology, University of Missouri, Columbia, Missouri
| | - Heike Wulff
- Department of Pharmacology, University of California Davis, Davis, California
| | - Michael A Hill
- Dalton Cardiovascular Research Institute and Dept. of Medical Pharmacology and Physiology, University of Missouri, Columbia, Missouri
| | - Andrew P Braun
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| |
Collapse
|
13
|
Mallat RK, John CM, Mishra RC, Kendrick DJ, Wulff H, Braun AP. In Vivo Targeting of the Endothelium to Improve Vascular Function in a Rodent Model of Type 2 Diabetes. FASEB J 2019. [DOI: 10.1096/fasebj.2019.33.1_supplement.685.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | | | - Ramesh C Mishra
- Physiology and PharmacologyUniversity of CalgaryCalgaryABCanada
| | | | - Heike Wulff
- PharmacologyUniversity of California DavisDavisCA
| | - Andrew P Braun
- Physiology and PharmacologyUniversity of CalgaryCalgaryABCanada
| |
Collapse
|
14
|
Mishra RC, Belke D, John CM, Wulff H, Braun AP. Prolonged Administration of the KCa Channel Activator SKA‐31 Improves Cardiac Function and Blood Pressure in Type 2 Diabetic Goto‐Kakizaki Rats. FASEB J 2019. [DOI: 10.1096/fasebj.2019.33.1_supplement.683.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Ramesh C Mishra
- Physiology and PharmacologyUniversity of CalgaryCalgaryABCanada
| | - Darrell Belke
- Cardiac SciencesUniversity of CalgaryCalgaryABCanada
| | | | - Heike Wulff
- PharmacologyUniversity of California DavisDavisCA
| | - Andrew P Braun
- Physiology and PharmacologyUniversity of CalgaryCalgaryABCanada
| |
Collapse
|
15
|
Khaddaj‐Mallat R, John C, Wulff H, Braun AP. Chronic administration of an endothelial KCa channel activator (SKA‐31) improves agonist evoked vasodilation in mesenteric arteries of aged rats. FASEB J 2018. [DOI: 10.1096/fasebj.2018.32.1_supplement.710.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Cini John
- Dept of Physiology and PharmacologyUniversity of CalgaryCalgaryABCanada
| | - Heike Wulff
- Dept of PharmacologyUniversity of California DavisDavisCA
| | - Andrew P. Braun
- Dept of Physiology and PharmacologyUniversity of CalgaryCalgaryABCanada
| |
Collapse
|
16
|
Mathew John C, Khaddaj Mallat R, George G, Kim T, Mishra RC, Braun AP. Pharmacologic targeting of endothelial Ca 2+-activated K + channels: A strategy to improve cardiovascular function. Channels (Austin) 2018; 12:126-136. [PMID: 29577810 PMCID: PMC5972810 DOI: 10.1080/19336950.2018.1454814] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2018] [Accepted: 03/15/2018] [Indexed: 12/17/2022] Open
Abstract
Endothelial small and intermediate-conductance, Ca2+-activated K+ channels (KCa2.3 and KCa3.1, respectively) play an important role in the regulation of vascular function and systemic blood pressure. Growing evidence indicates that they are intimately involved in agonist-evoked vasodilation of small resistance arteries throughout the circulation. Small molecule activators of KCa2.x and 3.1 channels, such as SKA-31, can acutely inhibit myogenic tone in isolated resistance arteries, induce effective vasodilation in intact vascular beds, such as the coronary circulation, and acutely decrease systemic blood pressure in vivo. The blood pressure-lowering effect of SKA-31, and early indications of improvement in endothelial dysfunction suggest that endothelial KCa channel activators could eventually be developed into a new class of endothelial targeted agents to combat hypertension or atherosclerosis. This review summarises recent insights into the activation of endothelial Ca2+ activated K+ channels in various vascular beds, and how tools, such as SKA-31, may be beneficial in disease-related conditions.
Collapse
Affiliation(s)
- Cini Mathew John
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Rayan Khaddaj Mallat
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Grace George
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Taeyeob Kim
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Ramesh C. Mishra
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Andrew P. Braun
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| |
Collapse
|
17
|
Kyle BD, Mishra RC, Braun AP. The augmentation of BK channel activity by nitric oxide signaling in rat cerebral arteries involves co-localized regulatory elements. J Cereb Blood Flow Metab 2017; 37:3759-3773. [PMID: 28155571 PMCID: PMC5718322 DOI: 10.1177/0271678x17691291] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Large conductance, Ca2+-activated K+ (BK) channels control cerebrovascular tone; however, the regulatory processes influencing these channels remain poorly understood. Here, we investigate the cellular mechanisms underlying the enhancement of BK current in rat cerebral arteries by nitric oxide (NO) signaling. In isolated cerebral myocytes, BK current magnitude was reversibly increased by sodium nitroprusside (SNP, 100 μM) and sensitive to the BK channel inhibitor, penitrem-A (100 nM). Fostriecin (30 nM), a protein phosphatase type 2A (PP2A) inhibitor, significantly prolonged the SNP-induced augmentation of BK current and a similar effect was produced by sildenafil (30 nM), a phosphodiesterase 5 (PDE5) inhibitor. Using proximity ligation assay (PLA)-based co-immunostaining, BK channels were observed to co-localize with PP2A, PDE5, and cGMP-dependent protein kinase (cGKI) (spatial restriction < 40 nm); cGKI co-localization increased following SNP exposure. SNP (10 μM) reversibly inhibited myogenic tone in cannulated cerebral arteries, which was augmented by either fostriecin or sildenafil and inhibited by penitrem-A. Collectively, these data suggest that (1) cGKI, PDE5, and PP2A are compartmentalized with cerebrovascular BK channels and determine the extent of BK current augmentation by NO/cGMP signaling, and (2) the dynamic regulation of BK activity by co-localized signaling enzymes modulates NO-evoked dilation of cerebral resistance arteries.
Collapse
Affiliation(s)
- Barry D Kyle
- Department of Physiology and Pharmacology and Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Ramesh C Mishra
- Department of Physiology and Pharmacology and Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Andrew P Braun
- Department of Physiology and Pharmacology and Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| |
Collapse
|
18
|
Khaddaj Mallat R, Mathew John C, Kendrick DJ, Braun AP. The vascular endothelium: A regulator of arterial tone and interface for the immune system. Crit Rev Clin Lab Sci 2017; 54:458-470. [PMID: 29084470 DOI: 10.1080/10408363.2017.1394267] [Citation(s) in RCA: 83] [Impact Index Per Article: 11.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
As the primary interface between the blood and various tissues of the body, the vascular endothelium exhibits a diverse range of roles and activities, all of which contribute to the overall health and function of the cardiovascular system. In this focused review, we discuss several key aspects of endothelial function, how this may be compromised and subsequent consequences. Specifically, we examine the dynamic regulation of arterial contractility and distribution of blood flow through the generation of chemical and electrical signaling events that impinge upon vascular smooth muscle. The endothelium can generate a diverse range of vasoactive compounds and signals, most of which act locally to adjust blood flow in a dynamic fashion to match tissue metabolism. Disruption of these vascular signaling processes (e.g. reduced nitric oxide bioavailability) is typically referred to as endothelial dysfunction, which is a recognized risk factor for cardiovascular disease in patients and occurs early in the development and progression of hypertension, atherosclerosis and tissue ischemia. Endothelial dysfunction is also associated with type-2 Diabetes and aging and increased mechanistic knowledge of the cellular changes contributing to these effects may provide important clues for interventional strategies. The endothelium also serves as the initial site of interaction for immune cells entering tissues in response to damage and acts to facilitate the actions of both the innate and acquired immune systems to interact with the vascular wall. In addition to representing the main cell type responsible for the formation of new blood vessels (i.e. angiogenesis) within the vasculature, the endothelium is also emerging as a source of extracellular vesicle or microparticles for the transport of signaling molecules and other cellular materials to nearby, or remote, sites in the body. The characteristics of released microparticles appear to change with the functional status of the endothelium; thus, these microparticles may represent novel biomarkers of endothelial health and more serious cardiovascular disease.
Collapse
Affiliation(s)
- Rayan Khaddaj Mallat
- a Department of Physiology and Pharmacology, Cumming School of Medicine , University of Calgary, and Libin Cardiovascular Institute of Alberta , Calgary , Canada
| | - Cini Mathew John
- a Department of Physiology and Pharmacology, Cumming School of Medicine , University of Calgary, and Libin Cardiovascular Institute of Alberta , Calgary , Canada
| | - Dylan J Kendrick
- a Department of Physiology and Pharmacology, Cumming School of Medicine , University of Calgary, and Libin Cardiovascular Institute of Alberta , Calgary , Canada
| | - Andrew P Braun
- a Department of Physiology and Pharmacology, Cumming School of Medicine , University of Calgary, and Libin Cardiovascular Institute of Alberta , Calgary , Canada
| |
Collapse
|
19
|
Abstract
Local blood flow autoregulation in response to intraluminal pressure requires small artery myogenic vasoconstriction, the extent of which is thought to be governed by a feedback process that depends on Ca2+ signaling. In this issue of Science Signaling, Khavandi et al suggest a role for cyclic guanosine monophosphate (cGMP)-dependent protein kinase G Iα (PKGIα) activated by oxidants in a cGMP-independent manner.
Collapse
Affiliation(s)
- Michael A Hill
- Dalton Cardiovascular Research Center and Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO 65211, USA.
| | - Andrew P Braun
- Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada
| |
Collapse
|
20
|
Braun AP, Phelps QE. Habitat Use by Five Turtle Species in the Middle Mississippi River. Chelonian Conservation and Biology 2016. [DOI: 10.2744/ccb-1156.1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
21
|
Kyle BD, Mishra RC, Braun AP. Evidence For Phosphorylation-Dependent Modulation of BK Channel Activity in Vascular Smooth Muscle (VSM) Myocytes and Resistance Arteries. Biophys J 2016. [DOI: 10.1016/j.bpj.2015.11.230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
22
|
Affiliation(s)
- Andrew P Braun
- a Department of Physiology and Pharmacology; Cumming School of Medicine ; University of Calgary ; Calgary ; Alberta Canada
| |
Collapse
|
23
|
Mishra RC, Mitchell JR, Gibbons-Kroeker C, Wulff H, Belenkie I, Tyberg JV, Braun AP. A pharmacologic activator of endothelial KCa channels increases systemic conductance and reduces arterial pressure in an anesthetized pig model. Vascul Pharmacol 2015; 79:24-31. [PMID: 26239885 DOI: 10.1016/j.vph.2015.07.016] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2015] [Revised: 07/24/2015] [Accepted: 07/28/2015] [Indexed: 11/27/2022]
Abstract
SKA-31, an activator of endothelial KCa2.3 and KCa3.1 channels, reduces systemic blood pressure in mice and dogs, however, its effects in larger mammals are not well known. We therefore examined the hemodynamic effects of SKA-31, along with sodium nitroprusside (SNP), in anesthetized, juvenile male domestic pigs. Experimentally, continuous measurements of left ventricular (LV), aortic and inferior vena cava (IVC) pressures, along with flows in the ascending aorta, carotid artery, left anterior descending coronary artery and renal artery, were performed during acute administration of SKA-31 (0.1, 0.3, 1.0, 3.0 and 5.0mg/ml/kg) and a single dose of SNP (5.0 μg/ml/kg). SKA-31 dose-dependently reduced mean aortic pressure (mPAO), with the highest dose decreasing mPAO to a similar extent as SNP (-23 ± 3 and -28 ± 4 mmHg, respectively). IVC pressure did not change. Systemic conductance and conductance in coronary and carotid arteries increased in response to SKA-31 and SNP, but renal artery conductance was unaffected. There was no change in either LV stroke volume (SV) or heart rate (versus the preceding control) for any infusion. With no change in SV, drug-evoked decreases in LV stroke work (SW) were attributed to reductions in mPAO (SW vs. mPAO, r(2)=0.82, P<0.001). In summary, SKA-31 dose-dependently reduced mPAO by increasing systemic and arterial conductances. Primary reductions in mPAO by SKA-31 largely account for associated decreases in SW, implying that SKA-31 does not directly impair cardiac contractility.
Collapse
Affiliation(s)
- Ramesh C Mishra
- Dept. of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; The Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada
| | - Jamie R Mitchell
- Dept of Physiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
| | - Carol Gibbons-Kroeker
- Dept. of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Dept. of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; The Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada; Dept. of Biology, Ambrose University College, Calgary, Alberta, Canada
| | - Heike Wulff
- Dept. of Pharmacology, University of California Davis, Davis, CA, USA
| | - Israel Belenkie
- Dept. of Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Dept. of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; The Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada
| | - John V Tyberg
- Dept. of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Dept. of Cardiac Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; The Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada
| | - Andrew P Braun
- Dept. of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; The Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.
| |
Collapse
|
24
|
Abstract
To maintain health and function in response to inhaled environmental irritants and toxins, the lungs and airways depend upon an innate defense system that involves the secretion of mucus (i.e., mucin, salts, and water) by airway epithelium onto the apical surface to trap foreign particles. Airway mucus is then transported in an oral direction via ciliary beating and coughing, which helps to keep the airways clear. CFTR (cystic fibrosis transmembrane conductance regulator) is a cAMP-regulated Cl- channel in the apical membrane of epithelium that contributes to salt and water secretion onto the luminal surface of airways, thereby ensuring that secreted mucus is sufficiently hydrated for movement along the epithelial surface. Dehydration of airway mucus, as occurs in cystic fibrosis, results in a more viscous, less mobile secretion that compromises the lung’s innate defense system by facilitating a build-up of foreign particles and bacterial growth. Related to this situation is chronic obstructive pulmonary disease (COPD), which is a leading cause of death globally. A major cause of COPD is cigarette smoking, which has been reported to decrease the cellular levels of CFTR in airway epithelia. In their recent article, Rasmussen and coworkers now report that exposure to cigarette smoke elevates cytosolic free Ca2+ in airway epithelium, leading to decreased surface localization and cellular expression of CFTR and reduced levels of secreted airway surface liquid. Blocking this increase in cytosolic Ca2+ largely prevented CFTR loss in airway epithelium and surprisingly, cellular lysosomes appear to be a major source for smoke-induced Ca2+ elevation.
Collapse
|
25
|
Braun AP. Some assembly required: SOCE and Orai1 channels couple to NFAT transcriptional activity via calmodulin and calcineurin. Channels (Austin) 2015; 8:383-4. [PMID: 25483577 DOI: 10.4161/19336950.2014.951250] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Advances in our ability to monitor the temporal and spatial dynamics of intracellular second messengers such as Ca(2+) and cyclic nucleotides at millisecond and sub-micron levels of resolution have greatly increased our understanding of cellular signal transduction mechanisms. Thus, it is now well appreciated that second messengers can rise and fall within discrete regions of the intracellular compartment, as opposed to global changes, and on a time scale determined by the local collection of signaling molecules responsible for the synthesis and degradation/re-uptake of the second messenger. Efforts to identify the components of such macromolecular signaling domains have revealed the presence of hormone receptors, modifying enzymes and scaffolding proteins that tend to assemble and organize these complexes. Emerging evidence now suggests that these signal transduction entities need not be pre-existing, static complexes within the cell, but in fact, may dynamically assemble in response to a specific stimulus. Such an arrangement would thus allow key signaling molecules to be trafficked where they are needed, thereby allowing a cell to utilize these resources more effectively. On the flip side, having such molecules constantly remain within a single cellular domain would facilitate rapid signaling responses and help maintain fidelity of the pathway.
Collapse
|
26
|
Donnelier J, Braun ST, Dolzhanskaya N, Ahrendt E, Braun AP, Velinov M, Braun JEA. Increased Expression of the Large Conductance, Calcium-Activated K+ (BK) Channel in Adult-Onset Neuronal Ceroid Lipofuscinosis. PLoS One 2015; 10:e0125205. [PMID: 25905915 PMCID: PMC4407904 DOI: 10.1371/journal.pone.0125205] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2014] [Accepted: 02/17/2015] [Indexed: 01/18/2023] Open
Abstract
Cysteine string protein (CSPα) is a presynaptic J protein co-chaperone that opposes neurodegeneration. Mutations in CSPα (i.e., Leu115 to Arg substitution or deletion (Δ) of Leu116) cause adult neuronal ceroid lipofuscinosis (ANCL), a dominantly inherited neurodegenerative disease. We have previously demonstrated that CSPα limits the expression of large conductance, calcium-activated K+ (BK) channels in neurons, which may impact synaptic excitability and neurotransmission. Here we show by western blot analysis that expression of the pore-forming BKα subunit is elevated ~2.5 fold in the post-mortem cortex of a 36-year-old patient with the Leu116∆ CSPα mutation. Moreover, we find that the increase in BKα subunit level is selective for ANCL and not a general feature of neurodegenerative conditions. While reduced levels of CSPα are found in some postmortem cortex specimens from Alzheimer's disease patients, we find no concomitant increase in BKα subunit expression in Alzheimer's specimens. Both CSPα monomer and oligomer expression are reduced in synaptosomes prepared from ANCL cortex compared with control. In a cultured neuronal cell model, CSPα oligomers are short lived. The results of this study indicate that the Leu116∆ mutation leads to elevated BKα subunit levels in human cortex and extend our initial work in rodent models demonstrating the modulation of BKα subunit levels by the same CSPα mutation. While the precise sequence of pathogenic events still remains to be elucidated, our findings suggest that dysregulation of BK channels may contribute to neurodegeneration in ANCL.
Collapse
Affiliation(s)
- Julien Donnelier
- Department of Biochemistry and Molecular Biology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Samuel T. Braun
- Department of Biochemistry and Molecular Biology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | | | - Eva Ahrendt
- Department of Biochemistry and Molecular Biology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Andrew P. Braun
- Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Milen Velinov
- Albert Einstein College of Medicine, Bronx, New York, United States of America
- New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York, United States of America
| | - Janice E. A. Braun
- Department of Biochemistry and Molecular Biology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
- * E-mail:
| |
Collapse
|
27
|
Abstract
The allosterically-induced outcome of nitric oxide (NO) binding to soluble guanylate cyclase (sGC) is well known but poorly understood. As described in this issue of Structure, Underbakke and coworkers apply a powerful hydrogen/deuterium exchange method to follow the key structural elements of the pathway between NO binding and sGC catalytic site activation.
Collapse
Affiliation(s)
- Andrew P Braun
- Department of Physiology and Pharmacology, Faculty of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada
| | - David C Schriemer
- Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.
| |
Collapse
|
28
|
Braun AP. Cooperative interactions between subunits regulate gating in holo-proton conductive channels. Channels (Austin) 2014. [DOI: 10.4161/chan.4.2.12111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
29
|
|
30
|
Braun AP. Multi-tasking at the protein level: L-type calcium channels function as ionotropic and metabotropic activators of smooth muscle contraction. Channels (Austin) 2014; 5:459-60. [DOI: 10.4161/chan.5.6.17996] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
31
|
Abstract
Large conductance, Ca2+-activated K+ (BK) channels represent an important pathway for the outward flux of K+ ions from the intracellular compartment in response to membrane depolarization, and/or an elevation in cytosolic free [Ca2+]. They are functionally expressed in a range of mammalian tissues (e.g., nerve and smooth muscles), where they can either enhance or dampen membrane excitability. The diversity of BK channel activity results from the considerable alternative mRNA splicing and post-translational modification (e.g., phosphorylation) of key domains within the pore-forming α subunit of the channel complex. Most of these modifications are regulated by distinct upstream cell signaling pathways that influence the structure and/or gating properties of the holo-channel and ultimately, cellular function. The channel complex may also contain auxiliary subunits that further affect channel gating and behavior, often in a tissue-specific manner. Recent studies in human and animal models have provided strong evidence that abnormal BK channel expression/function contributes to a range of pathologies in nerve and smooth muscle. By targeting the upstream regulatory events modulating BK channel behavior, it may be possible to therapeutically intervene and alter BK channel expression/function in a beneficial manner.
Collapse
Affiliation(s)
- Barry D Kyle
- Department of Physiology and Pharmacology, Cumming School of Medicine, Libin Cardiovascular Research Institute, University of Calgary Calgary, AB, Canada
| | - Andrew P Braun
- Department of Physiology and Pharmacology, Cumming School of Medicine, Libin Cardiovascular Research Institute, University of Calgary Calgary, AB, Canada
| |
Collapse
|
32
|
Harraz OF, Abd El-Rahman RR, Bigdely-Shamloo K, Wilson SM, Brett SE, Romero M, Gonzales AL, Earley S, Vigmond EJ, Nygren A, Menon BK, Mufti RE, Watson T, Starreveld Y, Furstenhaupt T, Muellerleile PR, Kurjiaka DT, Kyle BD, Braun AP, Welsh DG. Ca(V)3.2 channels and the induction of negative feedback in cerebral arteries. Circ Res 2014; 115:650-61. [PMID: 25085940 DOI: 10.1161/circresaha.114.304056] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
RATIONALE T-type (CaV3.1/CaV3.2) Ca(2+) channels are expressed in rat cerebral arterial smooth muscle. Although present, their functional significance remains uncertain with findings pointing to a variety of roles. OBJECTIVE This study tested whether CaV3.2 channels mediate a negative feedback response by triggering Ca(2+) sparks, discrete events that initiate arterial hyperpolarization by activating large-conductance Ca(2+)-activated K(+) channels. METHODS AND RESULTS Micromolar Ni(2+), an agent that selectively blocks CaV3.2 but not CaV1.2/CaV3.1, was first shown to depolarize/constrict pressurized rat cerebral arteries; no effect was observed in CaV3.2(-/-) arteries. Structural analysis using 3-dimensional tomography, immunolabeling, and a proximity ligation assay next revealed the existence of microdomains in cerebral arterial smooth muscle which comprised sarcoplasmic reticulum and caveolae. Within these discrete structures, CaV3.2 and ryanodine receptor resided in close apposition to one another. Computational modeling revealed that Ca(2+) influx through CaV3.2 could repetitively activate ryanodine receptor, inducing discrete Ca(2+)-induced Ca(2+) release events in a voltage-dependent manner. In keeping with theoretical observations, rapid Ca(2+) imaging and perforated patch clamp electrophysiology demonstrated that Ni(2+) suppressed Ca(2+) sparks and consequently spontaneous transient outward K(+) currents, large-conductance Ca(2+)-activated K(+) channel mediated events. Additional functional work on pressurized arteries noted that paxilline, a large-conductance Ca(2+)-activated K(+) channel inhibitor, elicited arterial constriction equivalent, and not additive, to Ni(2+). Key experiments on human cerebral arteries indicate that CaV3.2 is present and drives a comparable response to moderate constriction. CONCLUSIONS These findings indicate for the first time that CaV3.2 channels localize to discrete microdomains and drive ryanodine receptor-mediated Ca(2+) sparks, enabling large-conductance Ca(2+)-activated K(+) channel activation, hyperpolarization, and attenuation of cerebral arterial constriction.
Collapse
Affiliation(s)
- Osama F Harraz
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Rasha R Abd El-Rahman
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Kamran Bigdely-Shamloo
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Sean M Wilson
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Suzanne E Brett
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Monica Romero
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Albert L Gonzales
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Scott Earley
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Edward J Vigmond
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Anders Nygren
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Bijoy K Menon
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Rania E Mufti
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Tim Watson
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Yves Starreveld
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Tobias Furstenhaupt
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Philip R Muellerleile
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - David T Kurjiaka
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Barry D Kyle
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Andrew P Braun
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.)
| | - Donald G Welsh
- From the Department of Physiology and Pharmacology, Hotchkiss Brain and Libin Cardiovascular Institutes (O.F.H., R.R.A.E.-R., K.B.-S., S.E.B., R.E.M., B.D.K., A.P.B., D.G.W.), Department of Electrical and Computer Engineering (K.B.-S., E.J.V., A.N.), Department of Clinical Neurosciences (B.K.M., T.W., Y.S.), and Microscopy Imaging Facility (T.F.), University of Calgary, Calgary, Alberta, Canada; Department of Pharmacology and Toxicology, Alexandria University, Alexandria, Egypt (O.F.H.); Division of Pharmacology, Loma Linda University, CA (S.M.W., M.R.); Department of Biomedical Sciences, Colorado State University, Fort Collins (A.L.G.); Department of Pharmacology, University of Nevada, Reno (S.E.); LIRYC Institute and Lab IMB, University of Bordeaux, Bordeaux, France (E.J.V.); and Department of Biomedical Sciences, Grand Valley State University, Allendale, MI (P.R.M., D.T.K.). dwelsh@ucalgary
| |
Collapse
|
33
|
Ahrendt E, Kyle B, Braun AP, Braun JEA. Cysteine string protein limits expression of the large conductance, calcium-activated K⁺ (BK) channel. PLoS One 2014; 9:e86586. [PMID: 24475152 PMCID: PMC3903548 DOI: 10.1371/journal.pone.0086586] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2013] [Accepted: 12/15/2013] [Indexed: 01/12/2023] Open
Abstract
Large-conductance, calcium-activated K+ (BK) channels are widely distributed throughout the nervous system and play an essential role in regulation of action potential duration and firing frequency, along with neurotransmitter release at the presynaptic terminal. We have previously demonstrated that select mutations in cysteine string protein (CSPα), a presynaptic J-protein and co-chaperone, increase BK channel expression. This observation raised the possibility that wild-type CSPα normally functions to limit neuronal BK channel expression. Here we show by Western blot analysis of transfected neuroblastoma cells that when BK channels are present at elevated levels, CSPα acts to reduce expression. Moreover, we demonstrate that the accessory subunits, BKβ4 and BKβ1 do not alter CSPα-mediated reduction of expressed BKα subunits. Structure-function analysis reveals that the N-terminal J-domain of CSPα is critical for the observed regulation of BK channels levels. Finally, we demonstrate that CSPα limits BK current amplitude, while the loss-of-function homologue CSPαHPD-AAA increases BK current. Our observations indicate that CSPα has a role in regulating synaptic excitability and neurotransmission by limiting expression of BK channels.
Collapse
Affiliation(s)
- Eva Ahrendt
- Department of Physiology and Pharmacology, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
| | - Barry Kyle
- Libin Cardiovascular Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Andrew P. Braun
- Libin Cardiovascular Institute, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Janice E. A. Braun
- Department of Physiology and Pharmacology, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
- * E-mail:
| |
Collapse
|
34
|
Braun AP. Built for speed: molecular properties of the voltage sensor domain underlie the rapid activation of voltage-gated Na(+) channels compared with Shaker-type K(+) channels. Channels (Austin) 2013; 7:423-5. [PMID: 24366114 PMCID: PMC4042476 DOI: 10.4161/chan.27652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Many of us were taught in high school biology that the action potential waveform in nerves and other excitable tissues was generated by an initial rapid influx of external Na+ ions across the plasma membrane, followed by an outward movement of intracellular K+ ions. The former event, mediated by voltage-gated Na+ channels, is responsible for the fast depolarizing upstroke of the action potential, while voltage-gated K+ channels are responsible for the subsequent repolarizing phase, which largely controls action potential duration. Although Hodgkin and Huxley described the fundamental importance of this sequential activation process more than 60 y ago, the molecular and structural details underlying the faster activation of voltage-gated Na+ (Nav) vs. K+ (Kv) channels have yet to be fully resolved.
Collapse
Affiliation(s)
- Andrew P Braun
- Faculty of Medicine; University of Calgary; Calgary, Alberta, Canada
| |
Collapse
|
35
|
Braun AP. Turning up the heat on L-type Ca2+ channels promotes neuronal firing and seizure activity. Channels (Austin) 2013; 7:229-30. [PMID: 25225705 PMCID: PMC3989350 DOI: 10.4161/chan.25956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
It is well recognized clinically that fever in young children (< 6 y of age) may lead to seizure activity in a small, but significant percentage of these individuals, which may have negative consequences for the developing brain and progressive cognitive function. In rodent models, exposure of acute brain slices to hyperthermic temperatures (i.e., 38-41 °C) is reported to evoke membrane depolarization and increased neuronal firing, although the underlying molecular/cellular events responsible for these phenomena are not fully understood. Elevated temperature may alter membrane excitability by influencing individual ion channels within a given neuron, or alter the behavior and connectivity of neurons and glia that operate within a local network. In the present study, Radzicki and colleagues have examined the possibility that modest increases in tissue/body temperature (up to 40.5 °C) may enhance the activity of voltage-gated Ca(2+) channels, which could then promote spontaneous firing of individual neurons and greater network discharge. The results of this work indicate that fever-like temperatures positively and reversibly influence the gating properties of L-type Ca(2+) channels, and that the L-type blocker nimodipine reduces both temperature-induced increases in spontaneous neuronal firing and the incidence/duration of discharge activity in a whole animal model of febrile seizure.
Collapse
|
36
|
Mishra RC, Mitchell J, Wulff H, Belenkie I, Tyberg JV, Braun AP. SKA‐31, a positive modulator of SK
Ca
and IK
Ca
channels, increases systemic conductance and lowers arrterial pressure in an anesthetized pig model. FASEB J 2013. [DOI: 10.1096/fasebj.27.1_supplement.900.7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Ramesh C Mishra
- Physiology and PharmacologyUniversity of CalgaryCalgaryABCanada
| | | | | | | | - John V Tyberg
- Cardiac SciencesUniversity of CalgaryCalgaryABCanada
| | - Andrew P Braun
- Physiology and PharmacologyUniversity of CalgaryCalgaryABCanada
| |
Collapse
|
37
|
Braun AP. CRACking the structure of Orai. Channels (Austin) 2013; 7:71-3. [PMID: 23502496 PMCID: PMC3667887 DOI: 10.4161/chan.24163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
38
|
Kyle BD, Hurst S, Swayze RD, Sheng J, Braun AP. Specific phosphorylation sites underlie the stimulation of a large conductance, Ca(2+)-activated K(+) channel by cGMP-dependent protein kinase. FASEB J 2013; 27:2027-38. [PMID: 23407708 DOI: 10.1096/fj.12-223669] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Smooth muscle contractility and neuronal excitability are regulated by large conductance, Ca(2+)-activated K(+) (BKCa) channels, the activity of which can be increased after modulation by type I cGMP-dependent protein kinase (cGKI) via nitric oxide (NO)/cGMP signaling. Our study focused on identifying key phosphorylation sites within the BKCa channel underlying functional enhancement of channel activity by cGKI. BKCa channel phosphorylation by cGKIα was characterized biochemically using radiolabeled ATP, and regulation of channel activity by NO/cGMP signaling was quantified in rat aortic A7r5 smooth muscle cells by cell-attached patch-clamp recording. Serine to alanine substitutions at 3 of 6 putative cGKI phosphorylation sites (Ser691, Ser873, and Ser1112) in the BKCa α subunit individually reduced direct channel phosphorylation by 25-60% and blocked BKCa activation by either an NO donor or a membrane-permeable cGMP by 80-100%. Acute inhibition of cGKI prevented stimulus-evoked enhancement of BKCa channel activity. Our data further suggest that augmentation of BKCa activity by NO/cGMP/cGKI signaling requires phosphorylation at all 3 sites and is independent of elevations in [Ca(2+)]i. Phosphorylation of 3 specific Ser residues within the murine BKCa α subunit by cGKIα accounts for the enhanced BKCa channel activity induced by elevated [cGMP]i in situ.
Collapse
Affiliation(s)
- Barry D Kyle
- Department of Physiology and Pharmacology and the Libin Cardiovascular Research Institute, University of Calgary, Calgary, Alberta, Canada
| | | | | | | | | |
Collapse
|
39
|
Yang Y, Sohma Y, Nourian Z, Ella SR, Li M, Stupica A, Korthuis RJ, Davis MJ, Braun AP, Hill MA. Mechanisms underlying regional differences in the Ca2+ sensitivity of BK(Ca) current in arteriolar smooth muscle. J Physiol 2013; 591:1277-93. [PMID: 23297302 DOI: 10.1113/jphysiol.2012.241562] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
Abstract β1-Subunits enhance the gating properties of large-conductance Ca(2+)-activated K(+) channels (BKCa) formed by α-subunits. In arterial vascular smooth muscle cells (VSMCs), β1-subunits are vital in coupling SR-generated Ca(2+) sparks to BKCa activation, affecting contractility and blood pressure. Studies in cremaster and cerebral VSMCs show heterogeneity of BKCa activity due to apparent differences in the functional β1-subunit:α-subunit ratio. To define these differences, studies were conducted at the single-channel level while siRNA was used to manipulate specific subunit expression. β1 modulation of the α-subunit Ca(2+) sensitivity was studied using patch-clamp techniques. BKCa channel normalized open probability (NPo) versus membrane potential (Vm) curves were more left-shifted in cerebral versus cremaster VSMCs as cytoplasmic Ca(2+) was raised from 0.5 to 100 μm. Calculated V1/2 values of channel activation decreased from 72.0 ± 6.1 at 0.5 μm Ca(2+)i to -89 ± 9 mV at 100 μm Ca(2+)i in cerebral compared with 101 ± 10 to -63 ± 7 mV in cremaster VSMCs. Cremaster BKCa channels thus demonstrated an ∼2.5-fold weaker apparent Ca(2+) sensitivity such that at a value of Vm of -30 mV, a mean value of [Ca(2+)]i of 39 μm was required to open half of the channels in cremaster versus 16 μm [Ca(2+)]i in cerebral VSMCs. Further, shortened mean open and longer mean closed times were evident in BKCa channel events from cremaster VSMCs at either -30 or 30 mV at any given [Ca(2+)]. β1-Subunit-directed siRNA decreased both the apparent Ca(2+) sensitivity of BKCa in cerebral VSMCs and the appearance of spontaneous transient outward currents. The data are consistent with a higher ratio of β1-subunit:α-subunit of BKCa channels in cerebral compared with cremaster VSMCs. Functionally, this leads both to higher Ca(2+) sensitivity and NPo for BKCa channels in the cerebral vasculature relative to that of skeletal muscle.
Collapse
Affiliation(s)
- Yan Yang
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO 65211, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Braun AP. Keeping active channels in their place: membrane phosphoinositides regulate TRPM channel activity in a compartment-selective manner. Channels (Austin) 2012; 6:407-8. [PMID: 23151432 PMCID: PMC3536723 DOI: 10.4161/chan.22897] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
We have long appreciated that the controlled movement of ions and solutes across the cell surface or plasma membrane affects every aspect of cell function, ranging from membrane excitability to metabolism to secretion, and is also critical for the long-term maintenance of cell viability. Studies examining these physiological transport processes have revealed a vast array of ion channels, transporters and ATPase-driven pumps that underlie these transmembrane ionic movements and how acquired or genetic disruption of these processes are linked to disease. More recently, it has become evident that the ongoing function of intracellular organelles and subcellular compartments also depends heavily on the controlled movement of ions to establish distinct pH or ionic environments. However, limited experimental access to these subcellular domains/structures has hampered scientific progress in this area, due in large part to the difficulty of applying proven functional assays, such as patch clamp and radiotracer methodologies, to these specialized membrane locations. Using both functional and immune-labeling assays, we now know that the types and complement of channels, transporters and pumps located within intracellular membranes and organelles often differ from those present on the plasma membrane. Moreover, it appears that this differential distribution is due to the presence of discrete tags/signals present within these transport proteins that dictate their sorting/trafficking to spatially discrete membrane compartments, where they may also interact with scaffolding proteins that help maintain their localization. Such targeting signals may thus operate in a manner analogous to the way a postal code is used to direct the delivery of a letter.
Collapse
Affiliation(s)
- Andrew P Braun
- Department of Physiology and Pharmacology, Faculty of Medicine, University of Calgary, Calgary, AB, Canada.
| |
Collapse
|
41
|
Mishra RC, Belke D, Wulff H, Braun AP. SKA-31, a novel activator of SK(Ca) and IK(Ca) channels, increases coronary flow in male and female rat hearts. Cardiovasc Res 2012; 97:339-48. [PMID: 23118129 DOI: 10.1093/cvr/cvs326] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
AIMS Endothelial SK(Ca) and IK(Ca) channels play an important role in the regulation of vascular function and systemic blood pressure. Based on our previous findings that small molecule activators of SK(Ca) and IK(Ca) channels (i.e. NS309 and SKA-31) can inhibit myogenic tone in isolated resistance arteries, we hypothesized that this class of compounds may induce effective vasodilation in an intact vascular bed, such as the coronary circulation. METHODS AND RESULTS In a Langendorff-perfused, beating rat heart preparation, acute bolus administrations of SKA-31 (0.01-5 µg) dose-dependently increased total coronary flow (25-30%) in both male and female hearts; these responses were associated with modest, secondary increases in left ventricular (LV) systolic pressure and heart rate. SKA-31 evoked responses in coronary flow, LV pressure, and heart rate were qualitatively comparable to acute responses evoked by bradykinin (1 µg) and adenosine (10 µg). In the presence of apamin and TRAM-34, selective blockers of SK(Ca) and IK(Ca) channels, respectively, SKA-31 and bradykinin-induced responses were largely inhibited, whereas the adenosine-induced changes were blocked by ∼40%; TRAM-34 alone produced less inhibition. Sodium nitroprusside (SNP, 0.2 μg bolus dose) evoked changes in coronary flow, LV pressure, and heart rate were similar to those induced by SKA-31, but were unaffected by apamin + TRAM-34. The NOS inhibitor L-NNA reduced bradykinin- and adenosine-evoked changes, but did not affect responses to either SKA-31 or SNP. CONCLUSION Our study demonstrates that SKA-31 can rapidly and reversibly induce dilation of the coronary circulation in intact functioning hearts under basal flow and contractility conditions.
Collapse
Affiliation(s)
- Ramesh C Mishra
- Department of Physiology and Pharmacology, Faculty of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, AB, Canada T2N 4N1
| | | | | | | |
Collapse
|
42
|
Abstract
The ability of cells to reliably fire action potentials is critically dependent upon the maintenance of a hyperpolarized resting potential, which allows voltage-gated Na(+) and Ca(2+) channels to recover from inactivation and open in response to a subsequent stimulus. Hodgkin and Huxley first recognized the functional importance a small, steady outward leak of K(+) ions to the resting potential, action potential generation and cellular excitability, and we now appreciate the contribution of inward rectifier-type K(+) channels (Kir or KCNJ channels) to this process. More recently, however, it has become evident that two-pore domain K(+) (K2P) channels also contribute to the steady outward leak of K(+) ions, and thus, maintenance of the resting potential. Molecular cloning efforts have demonstrated that K2P channel exist in yeast to humans, and represent a major branch in the K(+) channel superfamily. Humans express 15 types of K2P channels, which are grouped into six subfamilies, based on similarities in amino acid sequence and functional properties. Although K2P channels are not voltage-gated, due to the absence of a canonical voltage sensor domain, their activity can be regulated by a variety of stimuli, including mechanical force, polyunsaturated fatty acids (PUFAs) (e.g., arachidonic acid), volatile anesthetics, acidity/pH, pharmacologic agents, heat and signaling events, such as phosphorylation and protein-protein interactions. K2P channels thus represent important regulators of cellular excitability by virtue of their impact on the resting potential, and as such, have garnered considerable attention in recent years.
Collapse
Affiliation(s)
- Andrew P Braun
- Department of Physiology and Pharmacology, University of Calgary, AB Canada.
| |
Collapse
|
43
|
Yang Y, Braun AP, Davis MJ, Hill MA. Differences in phosphorylation‐mediated K+ channel regulation between vascular smooth muscle cells from cremaster and cerebral resistance vessels. FASEB J 2012. [DOI: 10.1096/fasebj.26.1_supplement.870.35] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Yan Yang
- Dalton Cardiovascular Research CtrUniversity of MissouriColumbiaMO
| | - Andrew P Braun
- Physiology and PharmacologyUniveristy of CalgaryCalgaryABCanada
| | - Michael J Davis
- Medical Pharmacology and PhysiologyUniversity of MissouriColumbiaMO
| | - Michael A Hill
- Dalton Cardiovascular Research CtrUniversity of MissouriColumbiaMO
| |
Collapse
|
44
|
Gui P, Braun AP, Davis MJ. Integrin‐dependent and ‐independent potentiation of BKCa channel current by cell stretch. FASEB J 2012. [DOI: 10.1096/fasebj.26.1_supplement.870.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Peichun Gui
- Dept. of Medical Pharmcology & PhysiologyU of Missouri-ColumbiaColumbiaMO
| | | | - Michael J Davis
- Dept. of Medical Pharmcology & PhysiologyU of Missouri-ColumbiaColumbiaMO
| |
Collapse
|
45
|
Mishra RC, Belke D, Wulff H, Braun AP. SKA‐31, an enhancer of SK
Ca
and IK
Ca
channels, increases coronary flow in normotensive rats. FASEB J 2012. [DOI: 10.1096/fasebj.26.1_supplement.857.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Ramesh C Mishra
- Physiology and PharmacologyUniversity of CalgaryCalgaryABCanada
| | | | | | - Andrew P Braun
- Physiology and PharmacologyUniversity of CalgaryCalgaryABCanada
| |
Collapse
|
46
|
Kyle BD, Hurst S, Braun AP. Enhancement of the large conductance, Ca
2+
‐activated K
+
(BK) channel current by cGMP‐dependent protein kinase requires multiple phosphorylation sites on the C‐terminal tail. FASEB J 2012. [DOI: 10.1096/fasebj.26.1_supplement.870.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Barry D Kyle
- Physiology and PharmacologyUniv of CalgaryCalgaryABCanada
| | - Soleil Hurst
- Physiology and PharmacologyUniv of CalgaryCalgaryABCanada
| | - Andrew P Braun
- Physiology and PharmacologyUniv of CalgaryCalgaryABCanada
| |
Collapse
|
47
|
Braun AP. Structural remodeling of the N-terminus tunes TRPA1 channel activation and regulates behavioral responses in Drosophila. Channels (Austin) 2012; 6:50-1. [PMID: 22388005 DOI: 10.4161/chan.19351] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Our bodies are constantly bombarded by a diversity of environmental stimuli, such as touch, taste, sound, smell, light, etc. To detect and process this broad array of signals, nature has evolved a variety of cellular sensory mechanisms and pathways that interface with the environment and transmit neural signals back to the CNS where they are translated into behavioral decisions. Transient Response Potential (TRP) cation channels were first identified in invertebrates (i.e., Drosophila) and represent a sizeable receptor/channel family in mammals, consisting of 28 individual members grouped into subclasses denoted TRPC, TRPV, TRPM, TRPML, TRPP and TRPA (for a recent review, see ref. 1). Although originally described as ion channels, we now know that many members of the TRP family also function as receptors for a range of stimuli, including temperature, pH, chemical compounds and membrane voltage. In fact, several TRP isoforms display multimodal sensitivity, meaning that they can respond to more than one stimulus. For example, TRPV1, or the capcaisin receptor, displays both thermal and chemical sensitivity, and the two stimuli may act synergistically to increase channel activity. Physiologically, TRP family members are expressed in a variety of sensory afferent nerves that feed environmental information to the CNS, and also in smaller C-type afferent fibers responsible for peripheral pain sensation and transmission. Therapeutically, manipulation of TRP channel activity may represent an effective strategy to treat peripheral pain associated with inflammation and chronic tissue injury.
Collapse
|
48
|
Nourian Z, Li M, Davis MJ, Braun AP, Hill MA. Molecular Characterization of Large Conductance, Ca
2+
‐activated, K
+
Channels (BK) in Arteries from Cerebral and Skeletal Muscle Vasculatures. FASEB J 2011. [DOI: 10.1096/fasebj.25.1_supplement.lb451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Min Li
- Dalton Cardiovascular Research Center
| | - Michael J Davis
- Medical Pharmacology and PhysiologyUniversity of MissouriColumbiaMO
| | - Andrew P Braun
- Physiology and PharmacologyUniversity of CalgaryCalgaryABCanada
| | | |
Collapse
|
49
|
Raqeeb A, Sheng J, Ao N, Braun AP. Purinergic P2Y2 receptors mediate rapid Ca(2+) mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells. Cell Calcium 2011; 49:240-8. [PMID: 21414662 DOI: 10.1016/j.ceca.2011.02.008] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2010] [Revised: 02/15/2011] [Accepted: 02/18/2011] [Indexed: 11/29/2022]
Abstract
In blood vessels, stimulation of the vascular endothelium by the Ca(2+)-mobilizing agonist ATP initiates a number of cellular events that cause relaxation of the adjacent smooth muscle layer. Although vascular endothelial cells are reported to express several subtypes of purinergic P2Y and P2X receptors, the major isoform(s) responsible for the ATP-induced generation of vasorelaxant signals in human endothelium has not been well characterized. To address this issue, ATP-evoked changes in cytosolic Ca(2+), membrane potential and acute nitric oxide production were measured in isolated human umbilical vein endothelial cells (HUVECs) and profiled using established P2X and P2Y receptor probes. Whereas selective P2X agonist (i.e. α,β-methyl ATP) and antagonists (i.e. TNP-ATP and PPADS) could neither mimic nor block the observed ATP-evoked cellular responses, the specific P2Y receptor agonist UTP functionally reproduced all the ATP-stimulated effects. Furthermore, both ATP and UTP induced intracellular Ca(2+) mobilization with comparable EC(50) values (i.e. 1-3μM). Collectively, these functional and pharmacological profiles strongly suggest that ATP acts primarily via a P2Y2 receptor sub-type in human endothelial cells. In support, P2Y2 receptor mRNA and protein were readily detected in isolated HUVECs, and siRNA-mediated knockdown of endogenous P2Y2 receptor protein significantly blunted the cytosolic Ca(2+) elevations in response to ATP and UTP, but did not affect the histamine-evoked response. In summary, these results identify the P2Y2 isoform as the major purinergic receptor in human vascular endothelial cells that mediates the cellular actions of ATP linked to vasorelaxation.
Collapse
Affiliation(s)
- Abdul Raqeeb
- Department of Physiology and Pharmacology, Faculty of Medicine, University of Calgary and Smooth Muscle Research Group, Libin Cardiovascular Institute, Calgary, Alberta, Canada T2N 4N1
| | | | | | | |
Collapse
|
50
|
Abstract
The large conductance, voltage- and Ca(2+) -activated K(+) (BK or Slo1) channel is widely expressed in mammalian cells/tissues (i.e. neurons, skeletal and smooth muscles, exocrine cells, the inner ear) and regulates action potential firing, muscle contraction and secretion. The large ionic conductance and unusual, dual stimulus-driven gating behavior of this channel have long intrigued membrane biophysicists, and recent structure/function analyses have provided increasingly detailed insights into the molecular "bells and whistles" that regulate BK channel activity. Now, in two complementary articles published by the groups of Rod MacKinnon and Youxing Jiang, high resolution x-ray crystal structures of the human BK channel's large cytoplasmic domain have been solved in both the absence and presence of bound Ca(2+), conditions which would presumably promote the resting and activated conformations of this large domain. Given the regulatory importance of the cytosolic domain on BK channel gating, these experimentally determined structures reveal a number of key insights, including: 1) the physical arrangement and interactions of the tandem RCK1 and RCK2 domains within a single channel subunit, 2) the assembly of the four large cytoplasmic domains into a symmetric, tetrameric complex, 3) the formation of the channel's "gating ring" structure, based on the assembly of the individual RCK1 and 2 domains, and 4) the structural elements underlying the regions critical for divalent metal ion binding (i.e. Ca (2+) and Mg (2+)) and their potential influence on conduction pore.
Collapse
Affiliation(s)
- Andrew P Braun
- Department of Physiology and Pharmacology, University of Calgary, AB, Canada.
| |
Collapse
|